Posts tagged with 'pharma'
A Lifesciences Lab Where Robots Do All the ExperimentsRead the rest of this entry »
In the heart of Silicon Valley is a biotech laboratory run by robots. They carry out experiments ordered by scientists anywhere in the world who simply login to the lab, describe their project, set options like the cells to use or the types of analyses to perform, and go on to do other things while the robots do the rest.
The Strateos lab in Menlo Park, California is as sophisticated …
Pharma's 2016 TV Spend Topped $2.2 BillionAnyone who watches TV, especially daytime TV, couldn't help but wonder just what kind of miracle drug Humira must be. Ads for the drug aired more than 69,000 times last year.Read the rest of this entry »
In order of how much its manufacturer, AbbVie spent touting Humira's uses:
- Arthritis -- $173 million
- Crohn's and colitis -- $118 million
- Psoriasis -- $54 million.
Among the top 20 brands advertised on TV, Humira's $344 million spend was …
Price Increases Are Pushing Healthcare Spending UpIncreases in the cost of medical services and pharmaceuticals pushed spending on health care up by 4.6% for the privately insured in 2015. It was the largest increase in the last three years, according to a new report from theRead the rest of this entry »
Health Care Cost Institute (HCCI).
The cost of outpatient, inpatient, professional services, and prescription drugs increased between 3.5-9% in 2015, a bigger hike than in the prior two years, …
Pharma CEOs See Opportunity Ahead"Pharma's future have never looked more promising -- or more ominous." That cautionary statement topping the front page of the last report in PWC's Pharma 2020 series could still stand today as a summary of the entire pharmaceuticals and life sciences industry.Read the rest of this entry »
PWC's most recent survey of the CEOs of 87 of the largest pharmaceutical companies found optimism about the growth of their individual revenues as well as with the …
Future Looks Strong For Europe's PharmaEurope's economic outlook may be murky, but the future for pharmaceutical growth is rosy.Read the rest of this entry »
EvaluatePharma's latest whitepaper, "Pharmaceutical Innovation in Europe," says with potential blockbuster drugs already on the market or in the pipeline, pharma's revenue is forecast to grow at an annual compound rate of 3.2%, twice the GDP of the European market.
"Despite all the challenges posed by payers and the increasing scrutiny on the price …
This Pill Will Make You SmarterWho doesn't want to be more alert, sharper, quicker with a better memory? A good night's sleep, exercise, nutrition and a cup of joe have all been shown to improve cognition. Some people -- students especially -- have tinkered with Ritalin and other similar drugs for a quick boost in brain ability, though researchers doubt they have much effect.Read the rest of this entry »
Now, though, a real-world "Limitless" pill may have been …
Pharmaceutical Industry Faces Shortening of ExclusivityA new bill to cut the exclusivity period for new biologics by 5 years is getting some bipartisan support in Congress, which is giving its proponents hope that 2016 might be the year it passes.Read the rest of this entry »
Previous attempts to reduce the 12 year period in which a developer has the exclusive right to market and sell a biologic have failed to make it through Congress. Now, in the wake of public …
Drug Price List Increases Lower This YearAfter a bruising year in which pharmaceutical companies came under attack for their drug pricing policies, indications are that this year price increases will be more modest.Read the rest of this entry »
Deutsche Bank analysts found the average industry increase was 5% through April. Last year, it was 7.8%.
Valeant is responsible for a good part of the lower increase. After hiking its list price by an industry-leading 25.8% in the first four months of …
Changes Are Needed In Clinical Development To Improve OutcomesDrug development is expensive and lengthy, averaging 10 years and $2.6 billion. Much of the time and expense is wrapped up in clinical trials which become more complex every year. At the same time, too many trials fail, creating a productivity challenge for the industry.Read the rest of this entry »
In a report on the 5th Annual CROWN Congress in Philadelphia earlier this year, Ed Miseta, Chief Editor of Clinical Leader, wrote …
Orphan Drug Sales Forecast to Grow 12% AnnuallyOrphan drug sales are forecast to total $178 billion through 2020, growing 11.7% annually over the five years, a rate almost double that of overall prescription drugs.Read the rest of this entry »
EvaluatePhama's new report on orphan drugs predicts that by 2020, they will account for a fifth of all prescription drug sales (excluding generics).
Defined as "a pharmaceutical product aimed at rare diseases or disorders," the number of these drugs available in the market …